Rallybio Corp (NASDAQ:RLYB)’s traded shares stood at 0.29 million during the last session, with the company’s beta value hitting -1.07. At the close of trading, the stock’s price was $0.5, to imply a decrease of -4.83% or -$0.02 in intraday trading. The RLYB share’s 52-week high remains $1.54, putting it -208.0% down since that peak but still an impressive 56.0% since price per share fell to its 52-week low of $0.22. The company has a valuation of $20.76M, with an average of 0.81 million shares in intraday trading volume over the past 10 days and average of 2.83 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Rallybio Corp (RLYB), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give RLYB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Rallybio Corp (NASDAQ:RLYB) trade information
After registering a -4.83% downside in the last session, Rallybio Corp (RLYB) has traded red over the past five days. The 5-day price performance for the stock is 15.98%, and 42.28% over 30 days. With these gigs, the year-to-date price performance is -62.78%. Short interest in Rallybio Corp (NASDAQ:RLYB) saw shorts transact 1.98 million shares and set a 0.24 days time to cover.
RLYB Dividends
Rallybio Corp has its next earnings report out on 2025-May-08. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Rallybio Corp (NASDAQ:RLYB)’s Major holders
Rallybio Corp insiders hold 4.16% of total outstanding shares, with institutional holders owning 75.17% of the shares at 78.43% float percentage. In total, 75.17% institutions holds shares in the company, led by VIKING GLOBAL INVESTORS LP. As of 2024-06-30, the company held over 4.19 million shares (or 10.288% of shares), all amounting to roughly $5.62 million.
The next major institution holding the largest number of shares is JOHNSON & JOHNSON with 3.64 million shares, or about 8.9184% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $4.87 million.
We also have abrdn Healthcare Investors and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Rallybio Corp (RLYB) shares. Going by data provided on Mar 31, 2025 , abrdn Healthcare Investors holds roughly 755.08 shares. This is just over 1.81% of the total shares, with a market valuation of $0.38 million. Data from the same date shows that the other fund manager holds a little less at 649.66, or 1.56% of the shares, all valued at about 0.32 million.
